
GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbo... GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0089 | -3.51639668115 | 0.2531 | 0.275 | 0.233 | 177942 | 0.2545443 | CS |
4 | -0.0058 | -2.32 | 0.25 | 0.2877 | 0.2275 | 315205 | 0.25037082 | CS |
12 | -0.0089 | -3.51639668115 | 0.2531 | 0.2877 | 0.1704 | 343683 | 0.23994745 | CS |
26 | -0.0437 | -15.1788815561 | 0.2879 | 0.37 | 0.1704 | 984290 | 0.30284017 | CS |
52 | -0.0358 | -12.7857142857 | 0.28 | 0.63 | 0.1406 | 6389821 | 0.4364281 | CS |
156 | -0.377 | -60.6889890534 | 0.6212 | 4.16 | 0.1406 | 2494768 | 0.6224786 | CS |
260 | -2.8358 | -92.0714285714 | 3.08 | 5.75 | 0.1406 | 1729303 | 0.92475183 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.